University of Texas; MD Anderson Cancer Center — Houston, Texas

University of Texas; MD Anderson Cancer Center is a clinical research site located in Houston, Texas, United States 77030.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

University of Texas; MD Anderson Cancer Center has participated in 2 clinical trials.

Therapeutic areas: AL Amyloidosis, Primary Systemic (AL) Amyloidosis.

Sponsors: Prothena Biosciences Ltd..

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Texas; MD Anderson Cancer Center?

University of Texas; MD Anderson Cancer Center has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Texas; MD Anderson Cancer Center conducted?

University of Texas; MD Anderson Cancer Center has 2 clinical trials on record. Their work covers AL Amyloidosis, Primary Systemic (AL) Amyloidosis.

Is University of Texas; MD Anderson Cancer Center accredited by Crixeo Health?

University of Texas; MD Anderson Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Texas; MD Anderson Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.